Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492

Abstract

Full text

Addition of an Author

Winifred W. Yu was not included as an author in the original publication [1]. The corrected Author Contributions Statement is shown here. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Author Contributions: N.G. provided clinical expertise and oversight for the study. M.B., S.G. and G.L.-O. contributed to the writing and to the design and interpretation of the analysis. B.R. performed the data analysis and contributed to the writing, design, and interpretation of the analysis. S.L., L.V. and M.A.C. contextualized the findings and contributed to the design and interpretation of the analysis. M.T., N.V., J.M.L. and J.S. provided clinical insights and contextualized the findings. N.W. and W.W.Y. conducted the systematic literature review. All authors have read and agreed to the published version of the manuscript.